FDA.reportPublic FDA data

bevacizumab-adcd 100 MG in 4 ML Injection

RxCUI
2627650
RxNorm name
bevacizumab-adcd 100 MG in 4 ML Injection
Display name
bevacizumab-adcd 100 MG in 4 ML Injection
Full name
bevacizumab-adcd 100 MG in 4 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761268Vegzelmabevacizumab-adcd351(k) BiosimilarRx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VegzelmaBEVACIZUMAB-ADCDCELLTRION USA, Inc.4cdcccda-7b9a-49d0-ac50-f4605a3c0ebe2025-05-08Warnings, Adverse reactionsExact identifier
rxcui: 2627650

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4cdcccda-7b9a-49d0-ac50-f4605a3c0ebebevacizumab-adcd 100 MG in 4 ML Injection [PSN] · 4 ML bevacizumab-adcd 25 MG/ML Injection [SCD] · bevacizumab-adcd 100 MG per 4 ML Injection [SY]34These highlights do not include all the information needed to use VEGZELMA safely and effectively. See full prescribing information for VEGZELMA. VEGZELMA (bevacizumab-adcd) injection, for intravenous use Initial U.S. Approval: 2022 VEGZELMA (bevacizumab-adcd) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences b20250508